Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mitra, Anita
IP2-ATLANTA, NCT03763253: Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms	Active, not recruiting	2	433	Europe	Standard of Care, Minimally Invasive Ablative Therapy (MIAT), Metastatic Directed Therapy (MDT), Radical Therapy (Prostatectomy or Radiotherapy)	Imperial College London, Wellcome Trust	Prostate Cancer, Metastatic Prostate Cancer	08/26	01/27
Shah, Taimur T
IP2-ATLANTA, NCT03763253: Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms	Active, not recruiting	2	433	Europe	Standard of Care, Minimally Invasive Ablative Therapy (MIAT), Metastatic Directed Therapy (MDT), Radical Therapy (Prostatectomy or Radiotherapy)	Imperial College London, Wellcome Trust	Prostate Cancer, Metastatic Prostate Cancer	08/26	01/27
IP10-COMPACT, NCT06453785: Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection	Not yet recruiting	N/A	85	Europe	Promaxo portable MRI	Imperial College London	Prostate Cancer	04/27	07/27

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mitra, Anita
IP2-ATLANTA, NCT03763253: Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms	Active, not recruiting	2	433	Europe	Standard of Care, Minimally Invasive Ablative Therapy (MIAT), Metastatic Directed Therapy (MDT), Radical Therapy (Prostatectomy or Radiotherapy)	Imperial College London, Wellcome Trust	Prostate Cancer, Metastatic Prostate Cancer	08/26	01/27
Shah, Taimur T
IP2-ATLANTA, NCT03763253: Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms	Active, not recruiting	2	433	Europe	Standard of Care, Minimally Invasive Ablative Therapy (MIAT), Metastatic Directed Therapy (MDT), Radical Therapy (Prostatectomy or Radiotherapy)	Imperial College London, Wellcome Trust	Prostate Cancer, Metastatic Prostate Cancer	08/26	01/27
IP10-COMPACT, NCT06453785: Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection	Not yet recruiting	N/A	85	Europe	Promaxo portable MRI	Imperial College London	Prostate Cancer	04/27	07/27